2
For sEvErAl yEArs, sCiEntists hAvE BEEn tEsting A suBstAnCE CAllED intErFEron (干扰素), A potEntiAl wonDEr Drug thAt is proving to BE EFFECtivE in trEAting A vAriEty oF AilmEnts, in CluDing virus inFECtions, BACtEriA inFECtions, AnD tumors. to DAtE, thE nEw Drug hAs pro vokED no nEgAtivE rEACtion oF suFFiCiEnt signiFiCAnCE to DisCourAgE its usE.But in spitE oF its suCCEss, lAst yEAr only onE grAm wAs proDuCED in thE EntirE worlD、
thE rEAson For thE sCArCity liEs in thE struCturE oF intErFEron.A、spECiEs oF spECiFiC pro tEin, thE intErFEron proDuCED From onE AnimAl spECiEs CAnnot BE usED in trEAting AnothEr AnimAl spECiEs. in othEr worDs, to trEAt humAn BEings, only intErFEron proDuCED By humAn BEings mAy BE usED、thE Drug is proDuCED By inFECting whitE BlooD CElls with A virus. For tunAtEly, it is so powErFul thAt thE Amount givEn EACh pAtiEnt pEr injECtion is vEry smAll.
unlikE AntiBiotiCs, intErFEron DoEs not AttACk gErms DirECtly. instEAD, it mAkEs unAF FECtED CElls rEsistAnt to inFECtion, AnD prEvEnts thE multipliCAtion oF virusEs within CElls.
As you might ConCluDE, onE oF thE most DrAmAtiC usEs oF intErFEron hAs BEEn in thE trEAtmEnt oF CAnCEr.Dr. hAns strAnDEr, rEsEArCh physiCiAn At swEDEn’s FAmous kArolinskA institutE, hAs trEAtED morE thAn onE hunDrED CAnCEr pAtiEnts with thE nEw Drug.Among A group oF sElECtED pAtiEnts who hAs unDErgonE surgiCAl proCEDurEs For ADvAnCED CAnCEr, hAlF wErE givEn intErFEron. thE survivAl rAtE ovEr A thrEE-yEAr pErioD wAs 70 pErCEnt Among thosE who wErE trEAtED with intErFEron As CompArED with only 10 to 30 pErCEnt Among thosE who hAvE rECEivED thE ConvEntionAl trEAtmEnts.
in thE unitED stAtEs, A lArgE-sCAlE projECt supportED By thEAmEriCAnCAnCEr soCiEty is now unDErwAy. iF thE ExpErimEnt is suCCEssFul, intErFEron CoulD BEComE onE oF thE grEA tEst mEDiCAl DisCovEriEs oF our timE.
whiCh oF thE Following is truE oF thE rEsults oFDr. strAnDEr’s ExpErimEntsA．Both intErFEron AnD ConvEntionAl trEAtmEnts shoulD BE usED to EnsurE thE survivAl oF thE pAtiEnts.
B．At thE EnD oF thrEE yEArs, only tEn to thirty pErCEnt oF thE pAtiEnts who hAD not rECEivED intErFEron DiED、
C．only thE pAtiEnts who rECEivED intErFEron survivED、
D．most oF thE pAtiEnts who wErE trEAtED with intErFEron survivE